Cyclin-dependent kinase inhibitor therapy for hematologic malignancies

P Bose, GL Simmons, S Grant - Expert opinion on investigational …, 2013 - Taylor & Francis
Introduction: Cyclin-dependent kinases (CDKs) regulate cell cycle progression. Certain
CDKs (eg, CDK7, CDK9) also control cellular transcription. Consequently, CDKs represent …
被引用次数：163 相关文章

Cyclin-dependent kinase inhibitor therapy for hematologic malignancies.

P Bose, GL Simmons, S Grant - Expert Opinion on Investigational …, 2013 - europepmc.org
INTRODUCTION—Cyclin-dependent kinases (CDKs) regulate cell cycle progression.
Certain CDKs (eg, CDK7, CDK9) also control cellular transcription. Consequently, CDKs …

Cyclin-dependent kinase inhibitor therapy for hematologic malignancies

P Bose, GL Simmons, S Grant - Expert Opinion on …, 2013 - mdanderson.elsevierpure.com
Abstract Introduction: Cyclin-dependent kinases (CDKs) regulate cell cycle progression.
Certain CDKs (eg, CDK7, CDK9) also control cellular transcription. Consequently, CDKs …
[HTML] nih.gov

[HTML][HTML] Cyclin-dependent kinase inhibitor therapy for hematologic malignancies

P Bose, GL Simmons, S Grant - Expert opinion on investigational …, 2013 - ncbi.nlm.nih.gov
INTRODUCTION—Cyclin-dependent kinases (CDKs) regulate cell cycle progression.
Certain CDKs (eg, CDK7, CDK9) also control cellular transcription. Consequently, CDKs …

Cyclin-dependent kinase inhibitor therapy for hematologic malignancies

P Bose, GL Simmons, S Grant - Expert opinion on …, 2013 - pubmed.ncbi.nlm.nih.gov
Introduction Cyclin-dependent kinases (CDKs) regulate cell cycle progression. Certain
CDKs (eg, CDK7, CDK9) also control cellular transcription. Consequently, CDKs represent …

[引用][C] Cyclin-dependent kinase inhibitor therapy for hematologic malignancies

P Bose, GL Simmons, S Grant - Expert Opinion on Investigational Drugs, 2013 - cir.nii.ac.jp
Cyclin-dependent kinase inhibitor therapy for hematologic malignancies | CiNii Research
CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データを …

Cyclin-dependent kinase inhibitor therapy for hematologic malignancies.

P Bose, GL Simmons, S Grant - Expert Opinion on Investigational …, 2013 - europepmc.org
Cyclin-dependent kinases (CDKs) regulate cell cycle progression. Certain CDKs (eg, CDK7,
CDK9) also control cellular transcription. Consequently, CDKs represent attractive targets for …